Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-30.91%
Price
23.07.26
€4.70
Summary
This prediction is currently active. Massive losses of -30.91% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -1.674% | -1.674% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat